High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms

Схожие документы

• Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
  по: Jeromin, Sabine, et al.
  Опубликовано: (2015)
• Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases
  по: Schnittger, Susanne, et al.
  Опубликовано: (2012)
• A Case of SF3B1-Positive Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis
  по: Lazo-Langner, Alejandro, et al.
  Опубликовано: (2019)
• A Case of SF3B1-Positive Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis
  по: Alejandro Lazo-Langner, et al.
  Опубликовано: (2019-02-01)
• Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
  по: Flach, Johanna, et al.
  Опубликовано: (2010)